Hepatitis-associated aplastic anemia (HAAA) is a rare illness, characterized by onset of
pancytopenia with a hypoplastic bone marrow that traditionally occurs within 6 months of an …

Abstract The North American Pediatric Aplastic Anemia Consortium (NAPAAC) is a group of
pediatric hematologist‐oncologists, hematopathologists, and bone marrow transplant …

The cause of pediatric acute liver failure (PALF) is unknown in up to 40% of cases. Evidence
suggests that aberrant immune system activation may play a role. We hypothesized that …

Hepatitis-associated aplastic anemia (HAAA), a rare subtype of aplastic anemia (AA), is
defined as bone marrow failure occurring after acute hepatitis. Severe HAAA requires …

Objectives: Hepatitis-associated aplastic anemia (HAA) is a rare variant of aplastic anemia
in which patients present with severe pancytopenia after an episode of acute hepatitis. The …

Abnormal activation of the immune system plays an important role in the pathogenesis of
aplastic anemia (AA). Various immune cells and cytokines constitute a complex immune …

Hepatitis-associated aplastic anemia (HAAA) is a rare variant of acquired aplastic anemia
characterized with a syndrome of bone marrow failure after hepatitis. We retrospectively …

Objectives: Hepatitis-associated aplastic anemia (HAAA) is a potentially life-threatening
diagnosis without clear treatment guidelines. The goal of the study was to characterize the …

Hepatitis-associated aplastic anemia (HAAA) accounts for 4% of autoimmune hepatitis in
children. An episode of seronegative autoimmune hepatitis is followed a few days or months …

Outcomes of allogeneic hematopoietic stem cell transplantation (HSCT) for hepatitis-
associated aplastic anemia have not been fully evaluated. In the present study, the …